High expression of maternal embryonic leucine-zipper kinase (MELK) impacts clinical outcomes in patients with ovarian cancer and its inhibition suppresses ovarian cancer cells growth ex vivo.

High expression of maternal embryonic leucine-zipper kinase (MELK) impacts clinical outcomes in patients with ovarian cancer and its inhibition suppresses ovarian cancer cells growth ex vivo. J Gynecol Oncol. 2020 Nov; 31(6):e93.

View in: PubMed

subject areas

Cell Line, Tumor
Cell Proliferation
Female
Humans
Leucine
Middle Aged
Ovarian Neoplasms

authors with profiles

Yusuke Nakamura